| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |